Literature DB >> 26883554

Effects of dietary supplementation of pioglitazone on metabolism, milk yield, and reproductive performance in transition dairy cows.

Ali Reza Yousefi1, Hamid Kohram2, Ahmad Zare Shahneh2, Mohammad Javad Zamiri3, Ali Akbar Fouladi-Nashta4.   

Abstract

The objective of this study was to investigate the effect of dietary supplementation of pioglitazone (PGT), a specific ligand for PPARγ, on metabolic dynamics, milk production, and reproductive performance of transition dairy cows. Eighty multiparous Holstein cows in their second or more lactations were blocked by the calving date and parity and assigned randomly to four dietary groups (n = 20 cow/treatment) including control (no PGT-/-), supplemented with PGT (6-mg PGT/kg body weight) from Day -14 to +21 relative to parturition (PGT+/+) or only during prepartum (PGT+/-) or postpartum periods (PGT-/+). Postpartum body condition score and body weight loss decreased (P < 0.05) in all PGT-supplemented groups. Milk yield was not affected by PGT supplementation (P > 0.05). Percentage of milk fat decreased (P < 0.05) in all PGT-treated groups; however, milk fat yield was lower (P < 0.05) in PGT (+/+) and PGT (+/-) groups compared with PGT (-/-). Peripartum (Day -7 to +7) concentrations of plasma nonesterified fatty acids and β-Hydroxybutyrate decreased in PGT (+/+) but not in the PGT (-/-) group (P < 0.05). During the postpartum period, PGT reduced (P > 0.05) plasma concentrations of nonesterified fatty acids in all PGT-treated groups but did not affect β-Hydroxybutyrate level. Plasma concentrations of triglycerides decreased in all PGT-supplemented groups. Supplementation of PGT increased the peripartum concentrations of plasma glucose in PGT (+/+) and PGT (+/-) groups compared with control. Plasma concentrations of insulin-like growth factor 1 were higher in PGT (+/+) compared with the control group during both the peripartum and postpartum periods. Plasma concentrations of growth hormone and insulin were not affected by PGT treatment (P > 0.05). Mean days to ovulation were lower in PGT (+/+) and PGT (-/+), and the proportion of cows ovulating by Day 14 postpartum was higher in PGT (+/+) compared with control. Days open were shorter in PGT (+/+), PGT (+/-), and PGT (-/+) groups compared with control. However, the proportion of pregnant cows at 120 days in milk were higher in all PGT-supplemented groups. The results showed positive effects of dietary supplementation of PGT, especially supplementation during both the prepartum and postpartum periods, on metabolic dynamics, ovarian function, and reproductive performance in transition dairy cows.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dairy cow; Insulin resistance; Metabolic dynamics; Milk yield; Pioglitazone; Reproductive performance

Mesh:

Substances:

Year:  2016        PMID: 26883554     DOI: 10.1016/j.theriogenology.2016.01.015

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  3 in total

1.  2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis.

Authors:  Fernanda Rosa; Johan S Osorio; Erminio Trevisi; Francisco Yanqui-Rivera; Charles T Estill; Massimo Bionaz
Journal:  PPAR Res       Date:  2017-06-27       Impact factor: 4.964

2.  Berberine supplementation modulates the somatotropic axis and ameliorates glucose tolerance in dairy goats during late gestation and early lactation.

Authors:  Navid Ghavipanje; Mohammad Hasan Fathi Nasri; Seyyed Homayoun Farhangfar; Seyyed Ehsan Ghiasi; Einar Vargas-Bello-Pérez
Journal:  BMC Vet Res       Date:  2022-09-24       Impact factor: 2.792

3.  Effects of a combination of plant bioactive lipid compounds and biotin compared with monensin on body condition, energy metabolism and milk performance in transition dairy cows.

Authors:  Janis Hausmann; Carolin Deiner; Amlan K Patra; Irmgard Immig; Alexander Starke; Jörg R Aschenbach
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.